What is Estrella Immunopharma Inc. (ESLA) stock price today?

Estrella Immunopharma Inc. (ESLA) currently trades at $1.64 per share. The stock has a market capitalization of $67.41M and a P/E ratio of —x.

Is ESLA stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Estrella Immunopharma Inc. has a Smart Value Score of 18/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

ESLA

Estrella Immunopharma Inc.

NASDAQ: ESLA · HEALTHCARE · BIOTECHNOLOGY

$1.64

+11.56% today

Updated 2026-04-30

Market cap

$67.41M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.35

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

Market cap

$67.41M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-0.35

Dividend yield

—

52W range

$1 – $3

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$12.00

+631.71%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

0 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-177487.00

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	—	$0.00	$0.00
Net income	$-996104.00	$-7.31M	$-8.85M	$-13.06M	$-613174.00
EPS	—	—	—	—	$-0.35
Free cash flow	$-1.04M	$-16.07M	$-7.64M	$-1.79M	$-177487.00
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ESLA	$67.41M	18	4.3	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Estrella Immunopharma Inc. trades at $1.64. Our Smart Value Score of 18/100 indicates the stock is weak.

Frequently asked questions

What is Estrella Immunopharma Inc.'s stock price?

Estrella Immunopharma Inc. (ESLA) trades at $1.64.

Is Estrella Immunopharma Inc. overvalued?

Smart Value Score 18/100 (Grade F, Strong Sell).

What is the price target of Estrella Immunopharma Inc. (ESLA)?

The analyst target price is $12.00, representing +631.7% upside from the current price of $1.64.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-268.50%

Beta0.58

50D MA$1.32

200D MA$1.38

Shares out0.04B

Float0.02B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ESLA vs LLY →ESLA vs JNJ →ESLA vs ABBV →Stock screener →